knowledge -WSS

knowledge

author：fashion 2025-09-30 16:29:35 - browse：9

President Biden's White House announced the first 10 medicines that will be up first in its new drug price negotiation program. Anna Moneymaker/Getty Images

WASHINGTON — Medicare on Tuesday announced it will negotiate prices for 10 drugs, including major blood thinners and diabetes medications, in the first round of its negotiation program created in Democrats’ drug pricing reform law.

The drugs include Bristol Myers Squibb’s blood thinner Eliquis, Boehringer Ingelheim and Eli Lilly’s diabetes drug Jardiance, Johnson & Johnson’s blood thinner Xarelto, Merck’s diabetes drug Januvia, AstraZeneca’s diabetes drug Farxiga, Novartis’ heart failure treatment Entresto, Amgen’s rheumatoid arthritis drug Enbrel, Johnson & Johnson and AbbVie’s blood cancer treatment Imbruvica, J&J’s anti-inflammatory medicine Stelara, and Novo Nordisk insulins that go by names including Fiasp and NovoLog.

The new prices will be announced on Sept. 1, 2024, and will go into effect on Jan. 1, 2026. The drugs were chosen from a list of 50 treatments that cost Medicare’s pharmacy drug benefit the most money. The selected medicines cost Medicare more than $50 billion and made up 20% of the Medicare program’s pharmacy drug costs over a one-year period, the Department of Health and Human Services said. (Read more here about the winners and losers of the selection.)

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Tori Bowie and the unacceptable rates of Black maternal death
Next article： Inside the rise of 'mukbang' eating videos

WSS

Biogen nominates mother of director’s child to replace him on board

Altering the blood type of lungs raises potential for universal organs for transplants

Inside the rise of 'mukbang' eating videos

Sea level rise could wash away turtle breeding grounds around the world, researchers say

Britain’s MI6 chief says his spies are using AI to disrupt flow of weapons to Russia

Johnson & Johnson sues to stop Medicare negotiation

hotspot

knowledge

explore

Medicare details structure of new drug price negotiation program

Timeline: Key moments in fight for gay rights

The cancer drug shortage isn’t new — and neither are the solutions

Xenotransplantation trials will require adjusting expectations, experts say

The cancer drug shortage isn’t new — and neither are the solutions

A look at other Americans who have crossed into North Korea over the years

Medical leaders decry Supreme Court decision on affirmative action

Israeli protesters block highways, train stations as Netanyahu moves ahead with judicial overhaul

New air purifier tech could be key to improving indoor air quality

Patients, doctors are clashing about side effects of hormonal birth control

focus

UK homeowners get some respite as inflation falls by more than anticipated to a 15

BridgeBio heart drug succeeds in pivotal study

Reanimated hearts work just as well for transplants, study finds

Timeline: Key moments in fight for gay rights

Britain’s MI6 chief says his spies are using AI to disrupt flow of weapons to Russia

Altering the blood type of lungs raises potential for universal organs for transplants

hotspot

focus

hotspot

Wikipedia